Jump Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$669K Buy
+25,608
New +$651K 0.01% 1359
2025
Q1
Sell
-48,612
Closed -$712K 2090
2024
Q4
$712K Buy
+48,612
New +$680K 0.01% 914
2024
Q3
Sell
-45,769
Closed -$389K 2190
2024
Q2
$389K Buy
+45,769
New +$407K 0.01% 1245
2023
Q2
Sell
-95,311
Closed -$862K 2231
2023
Q1
$862K Buy
95,311
+63,424
+199% +$553K 0.04% 661
2022
Q4
$251K Buy
+31,887
New +$224K 0.01% 1153
2022
Q3
Sell
-55,500
Closed -$294K 2041
2022
Q2
$294K Buy
55,500
+11,152
+25% +$67.4K 0.01% 1081
2022
Q1
$290K Buy
+44,348
New +$395K 0.01% 1083
2021
Q4
Sell
-33,841
Closed -$983K 1778
2021
Q3
$983K Buy
+33,841
New +$1.12M 0.07% 297
2021
Q2
Sell
-19,142
Closed -$604K 1436
2021
Q1
$604K Buy
+19,142
New +$778K 0.06% 353

Other funds holding ZYME

Jump Financial's ZYME Position: Q2 2026 in Review

Jump Financial opened a new position in Zymeworks (ZYME) in Q2 2026: 25,608 shares worth $669K. The stake represents 0.01% of the portfolio and ranks #1359 among its holdings. This is a return to the name: Jump Financial previously reported a position in ZYME as recently as Q4 2024.

Jump Financial first reported a position in ZYME in Q1 2021 and has held it in 9 quarters since. The position peaked at $983K in Q3 2021. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Jump Financial held 25,608 shares of Zymeworks worth $669K as of Q2 2026.
  • Zymeworks was a new Jump Financial position in Q2 2026.
  • Zymeworks made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1359 holding.
  • Jump Financial first reported a position in Zymeworks in Q1 2021 and has held it in 9 quarters since.
  • Jump Financial's Zymeworks position peaked at $983K in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.